Skip to Content
COVID-19 Response and Update

Supporting access for the people who need it most

Access is at the heart of everything we do.
We believe everyone deserves a fair chance at better health, which is why we offer support that helps eligible patients start and stay on their prescribed generic, biosimilar, or branded treatments. Since 2012, our Patient Assistance Program has helped thousands of eligible patients access their medicines at no cost.

Since 2012

Our Patient Assistance Program has helped thousands of eligible patients

How we support patients

Amneal Patient Assistance Program (PAP)

Eligible individuals can apply to receive free Amneal medications for up to one year, based on program criteria. The PAP supports select branded therapies and is designed to help patients who are uninsured, underinsured, or facing financial hardship.

Affordability support

We provide financial assistance resources for eligible patients who may not otherwise be able to afford their prescribed medicines. This includes charitable programs, discount options, and partnerships that expand access. Additional affordability programs — including co-pay savings and discount offerings — are available for certain branded medicines.

Insurance and reimbursement guidance

Our support teams help patients and caregivers navigate coverage, benefits, prior authorizations, and specialty pharmacy coordination so treatment can begin with confidence

Community access initiatives

Through partnerships and nonprofit programs, we help deliver medicines to low-income and uninsured patients across the country, reinforcing our long-standing commitment to public health.

Support for Specialty Medicines

Dedicated support programs are available for eligible patients prescribed certain Amneal Specialty therapies. Programs are tailored to the unique needs of each condition, enabling patients to focus on their health rather than the complexity of coverage and cost.

The Amneal Specialty Patient Assistance Program helps support eligible U.S.-based patients prescribed CREXONT®, Brekiya® (dihydroergotamine mesylate) autoinjector or Ongentys® opicapone capsules.

Patient Assistance Programs

Call for Patient Assistance Program Support

For CREXONT® (carbidopa and levodopa extended-release capsules)
or Ongentys® (opicapone) capsules

1-855-459-9909
Monday – Friday, 8:00am – 8:00pm EST
This is for U.S. patients only

For Brekiya® (dihydroergotamine mesylate) autoinjector
1-833-378-3674
Monday – Friday, 8:00am – 8:00pm EST
This is for U.S. patients only

Copay Savings Programs

Support for Biosciences Medicines

Patient Assistance Programs

The Amneal Biosciences Patient Assistance Program helps support patients prescribed ALYMSYS®, BORUZU®, FOCINVEZ™, FYLNETRA®, LIORESAL®, PEMRYDI RTU®, or RELEUKO®. U.S.-based eligible individuals may apply to receive free medication for up to one year.

Apply for patient assistance (Opens in a new tab)

Call for Patient Assistance Program Support

1-877-764-9021

Monday-Friday, 8:00 AM-5:00 PM CST

This is for U.S. patients only

PATHways® Support

PATHways® is Amneal’s dedicated access and reimbursement support program that helps support eligible U.S-based patients prescribed ALYMSYS®, BORUZU®, FOCINVEZ™, FYLNETRA®, PEMRYDI RTU®, or RELEUKO®.

Patients and providers receive personalized guidance throughout the access journey, including:

  • Benefits investigation
  • Prior-authorization and coverage support
  • Reimbursement navigation and claims assistance
  • Co-pay savings for eligible commercially insured patients
  • Dedicated Patient Access Specialists who work directly with patients and caregivers
Visit PATHways® (Opens in a new tab)

Savings & Support Programs for Generic Medicines

Amneal also offers savings programs for select products as listed below: